Validation of the Aldosteronoma Resolution Score as a Predictive Resolution Score of Hypertension After Unilateral Adrenalectomy for Primary Aldosteronism in a North-African Population.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
accepted:
10
08
2023
medline:
3
10
2023
pubmed:
5
9
2023
entrez:
4
9
2023
Statut:
ppublish
Résumé
Unilateral primary aldosteronism (UPA) is the most frequent surgically curable form of endocrine hypertension. Adrenalectomy is the cornerstone of treatment for UPA, but outcomes after surgery are variable. Aldosteronoma Resolution Score (ARS) is a four-item predictive score for the cure of hypertension after adrenalectomy for UPA and has been demonstrated to be valid in different populations. We aimed in this study to validate the accuracy of this score in a North-African population. Between 2000 and 2021, the charts of 71 Tunisian patients who underwent laparoscopic adrenalectomy for UPA were retrospectively reviewed. Postoperative outcomes were assessed using the primary aldosteronism surgical outcome (PASO) criterion. The accuracy of the ARS was determined retrospectively by receiver operating characteristic curve and area under the curve. Thirty-four patients (48%) had complete clinical success according to the PASO criteria. Multivariate regression analysis revealed that the main determinants of complete clinical success were the absence of diabetes (OR: 5.205), a BMI <30 (OR: 4.930), a number of antihypertensive medications ≤2 (OR: 8.667), a plasma ARR >332 (OR: 4.554) and an ARS score ≥3 (OR: 2.056). Cure rates were, respectively, 21.1, 51.6, and 66.6% for patients with a score ARS 0-1, 2-3, and 4-5. The AUC of the ARS was 0.837. The ARS is a sufficiently predictive score in our North-African population. It may be used preoperatively to predict the outcome after adrenalectomy in these populations.
Sections du résumé
BACKGROUND
Unilateral primary aldosteronism (UPA) is the most frequent surgically curable form of endocrine hypertension. Adrenalectomy is the cornerstone of treatment for UPA, but outcomes after surgery are variable. Aldosteronoma Resolution Score (ARS) is a four-item predictive score for the cure of hypertension after adrenalectomy for UPA and has been demonstrated to be valid in different populations. We aimed in this study to validate the accuracy of this score in a North-African population.
METHODS
Between 2000 and 2021, the charts of 71 Tunisian patients who underwent laparoscopic adrenalectomy for UPA were retrospectively reviewed. Postoperative outcomes were assessed using the primary aldosteronism surgical outcome (PASO) criterion. The accuracy of the ARS was determined retrospectively by receiver operating characteristic curve and area under the curve.
RESULTS
Thirty-four patients (48%) had complete clinical success according to the PASO criteria. Multivariate regression analysis revealed that the main determinants of complete clinical success were the absence of diabetes (OR: 5.205), a BMI <30 (OR: 4.930), a number of antihypertensive medications ≤2 (OR: 8.667), a plasma ARR >332 (OR: 4.554) and an ARS score ≥3 (OR: 2.056). Cure rates were, respectively, 21.1, 51.6, and 66.6% for patients with a score ARS 0-1, 2-3, and 4-5. The AUC of the ARS was 0.837.
CONCLUSION
The ARS is a sufficiently predictive score in our North-African population. It may be used preoperatively to predict the outcome after adrenalectomy in these populations.
Identifiants
pubmed: 37667066
doi: 10.1007/s00268-023-07155-6
pii: 10.1007/s00268-023-07155-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2776-2783Informations de copyright
© 2023. The Author(s) under exclusive licence to Société Internationale de Chirurgie.
Références
Conn JW (1955) Primary aldosteronism. J Lab Clin Med 45:661–664
pubmed: 14368032
Douma S, Petidis K, Doumas M et al (2008) Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 371:1921–1926
doi: 10.1016/S0140-6736(08)60834-X
pubmed: 18539224
Hannemann A, Wallaschofski H (2012) Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies-a review of the current literature. Horm Metab Res 44:157–162
doi: 10.1055/s-0031-1295438
pubmed: 22135219
Rossi GP, Bernini G, Caliumi C et al (2006) A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 48:2293–2300
doi: 10.1016/j.jacc.2006.07.059
pubmed: 17161262
Savard S, Amar L, Plouin PF et al (2013) Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study. Hypertension 62:331–336
doi: 10.1161/HYPERTENSIONAHA.113.01060
pubmed: 23753408
Catena C (2008) Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 14(168):80
doi: 10.1001/archinternmed.2007.33
Rossi GP, Bernini G, Desideri G et al (2006) Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension 48:232–238
doi: 10.1161/01.HYP.0000230444.01215.6a
pubmed: 16801482
Stowasser M (2001) New perspectives on the role of aldosterone excess in cardiovascular disease. Clin Exp Pharmacol Physiol 28:783–791
doi: 10.1046/j.1440-1681.2001.03523.x
pubmed: 11553016
Funder JW, et al (2016) The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101:1889–916
Benham JL, Eldoma M, Khokhar B et al (2016) Proportion of patients with hypertension resolution following adrenalectomy for primary aldosteronism: a systematic review and meta-analysis. J Clin Hypertens 18:1205–1212
doi: 10.1111/jch.12916
Steichen O, Zinzindohoué F, Plouin PF et al (2012) Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review. Horm Metab Res 44:221–227
doi: 10.1055/s-0031-1299681
pubmed: 22395801
Williams TA, Lenders JWM, Mulatero P et al (2017) Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 5(9):689–699
doi: 10.1016/S2213-8587(17)30135-3
pubmed: 28576687
pmcid: 5572673
Zarnegar R, Young WF, Lee J et al (2008) The Aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 247(3):511–518
doi: 10.1097/SLA.0b013e318165c075
pubmed: 18376197
Utsumi T, Kawamura K, Imamoto T et al (2012) High predictive accuracy of aldosteronoma resolution score in Japanese patients with aldosterone-producing adenoma. Surgery 151(3):437–443
doi: 10.1016/j.surg.2011.08.001
pubmed: 22000827
Pasquier L, Kirouani M, Fanget F et al (2017) Assessment of the aldosteronoma resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients. Langenbecks Arch Surg 402(2):309–314
doi: 10.1007/s00423-017-1557-x
pubmed: 28111697
International CONNsortium Study Group et al. (2019) Validation of the Aldosteronoma resolution score within current clinical practice. World J Surg 43(10):2459–2468
Nejjari C, Arharbi M, Chentir MT et al (2013) Epidemiological Trial of Hypertension in North Africa (ETHNA): an international multicentre study in Algeria, Morocco and Tunisia. J Hypertens 31:49–62
doi: 10.1097/HJH.0b013e32835a6611
pubmed: 23221932
Boujnah R, Nazek L, Maalej M et al (2018) Hypertension in Tunisian adults attending primary care physicians (ETHNA-Tunisia). Indian Heart J 70:544–547
doi: 10.1016/j.ihj.2017.11.005
pubmed: 30170651
Sywak M, Pasieka JL (2002) Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 89:1587–1593
doi: 10.1046/j.1365-2168.2002.02261.x
pubmed: 12445071
Stowasser M, Gordon RD (2016) Primary Aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney. Physiol Rev 96:1327–1384
doi: 10.1152/physrev.00026.2015
pubmed: 27535640
Romero-Velez G, Laird AM, Barajas ME et al (2021) Outcomes of Adrenalectomy and the Aldosteronoma resolution score in the black and hispanic population. World J Surg 45:1475–1482
doi: 10.1007/s00268-021-05967-y
pubmed: 33554297
pmcid: 8026410
Burrello J, Burrello A, Stowasser M et al (2020) The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary Aldosteronism. Ann Surg 272:1125–1132
doi: 10.1097/SLA.0000000000003200
pubmed: 30672800
O’Toole SM, Hornby C, Sze WC et al (2021) Performance evaluation of scoring systems for predicting postoperative hypertension cure in primary aldosteronism. Clin Endocrinol (Oxford) 95:576–586
doi: 10.1111/cen.14534
Kempers MJE (2009) Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary Aldosteronism. Ann Intern Med 151:329–337
doi: 10.7326/0003-4819-151-5-200909010-00007
pubmed: 19721021
Zarnegar R, Bloom AI, Lee J et al (2008) is adrenal venous sampling necessary in all patients with hyperaldosteronism before adrenalectomy? J Vasc Interv Radiol 19:66–71
doi: 10.1016/j.jvir.2007.08.022
pubmed: 18192469
Dekkers T, Prejbisz A, Kool LJS et al (2016) Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomized diagnostic trial. Lancet Diabetes Endocrinol 4:739–746
doi: 10.1016/S2213-8587(16)30100-0
pubmed: 27325147